Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership23,808 shares
Latest Disclosed Value $ 509,254
Quadrant Capital Group Llc ownership in PDC / Pediatrix Medical Group, Inc.

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 23,808 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $428,544 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 23,808 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $445,210 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 PEDIATRIX MEDICAL GROUP COM 58502B106 23,808 0 0.00 509 0.00 0.0152
2026-05-11 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 23,808 0 49 0.0369
2026-02-12 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 23,808 0 0.00 509 27.89 0.0154
2025-11-13 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 23,808 0 0.00 399 16.72 0.0130
2025-08-13 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 23,808 -514 -2.11 342 -3.12 0.0123
2025-05-13 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 24,322 21,283 700.33 352 802.56 0.0131
2025-02-13 2024-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 3,039 279 10.11 40 25.81 0.0027
2024-11-12 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,760 326 13.39 32 72.22 0.0022
2024-08-12 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,434 -2,844 -53.88 18 -65.38 0.0014
2024-05-15 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 5,278 4,290 434.21 53 477.78 0.0042
2024-02-08 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 988 -583 -37.11 9 -52.63 0.0008
2023-11-14 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,571 -620 -28.30 20 -38.71 0.0020
2023-08-10 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,191 -3,439 -61.08 31 -62.65 0.0031
2023-05-11 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 5,630 2,703 92.35 84 93.02 0.0087
2023-02-13 2022-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,927 1,755 149.74 43 126.32 0.0049
2022-11-10 2022-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 1,172 224 23.63 19 -5.00 0.0025
2022-08-09 2022-06-30 13F MEDNAX COM 58502B106 948 142 17.62 20 5.26 0.0027
2022-05-06 2022-03-31 13F MEDNAX COM 58502B106 806 -41 -4.84 19 -17.39 0.0023
2022-02-01 2021-12-31 13F MEDNAX COM 58502B106 847 -12 -1.40 23 -4.17 0.0027
2021-11-12 2021-09-30 13F MEDNAX COM 58502B106 859 136 18.81 24 9.09 0.0033
2021-08-09 2021-06-30 13F MEDNAX COM 58502B106 723 8 1.12 22 22.22 0.0032
2021-05-12 2021-03-31 13F MEDNAX COM 58502B106 715 15 2.14 18 5.88 0.0029
2021-02-16 2020-12-31 13F MEDNAX COM 58502B106 700 -169 -19.45 17 21.43 0.0032
2020-11-13 2020-09-30 13F MEDNAX COM 58502B106 869 21 2.48 14 -6.67 0.0031
2020-08-13 2020-06-30 13F MEDNAX COM 58502B106 848 283 50.09 15 114.29 0.0033
2020-05-15 2020-03-31 13F MEDNAX Com 58502B106 565 -681 -54.65 7 -75.86 0.0012
2020-03-19 2019-12-31 13F/A-1 MEDNAX Com 58502B106 1,246 279 28.85 29 52.63 0.0035
2020-02-03 2019-12-31 13F MEDNAX Com 58502B106 1,246 279 29 97.9948
2019-10-24 2019-09-30 13F MEDNAX COM 58502B106 967 222 29.80 19 18.75 0.0029
2019-07-24 2019-06-30 13F MEDNAX COM 58502B106 745 -264 -26.16 16 -38.46 0.0025
2019-04-29 2019-03-31 13F MEDNAX COM 58502B106 1,009 851 538.61 26 550.00 0.0046
2019-01-17 2018-12-31 13F MEDNAX COM 58502B106 158 -76 -32.48 4 -60.00 0.0011
2018-10-29 2018-09-30 13F MEDNAX COM 58502B106 234 0 0.00 10 11.11 0.0029
2018-08-08 2018-06-30 13F MEDNAX COM 58502B106 234 -225 -49.02 9 -60.87 0.0032
2018-05-10 2018-03-31 13F MEDNAX COM 58502B106 459 225 96.15 23 130.00 0.0083
2018-01-31 2017-12-31 13F MEDNAX COM 58502B106 234 73 45.34 10 66.67 0.0040
2017-10-13 2017-09-30 13F MEDNAX COM 58502B106 161 -824 -83.65 6 -89.83 0.0025
2017-08-14 2017-06-30 13F MEDNAX COM 58502B106 985 -176 -15.16 59 -22.37 0.0261
2017-04-10 2017-03-31 13F MEDNAX COM 58502B106 1,161 161 16.10 76 20.63 0.0334
2017-01-11 2016-12-31 13F MEDNAX COM 58502B106 1,000 3 0.30 63 0.00 0.0316
2016-10-25 2016-09-30 13F MEDNAX COM 58502B106 997 2 0.20 63 -8.70 0.0411
2016-07-28 2016-06-30 13F MEDNAX COM 58502B106 995 39 4.08 69 15.00 0.0475
2016-04-27 2016-03-31 13F MEDNAX COM 58502B106 956 -1,044 -52.20 60 -58.04 0.0389
2016-01-28 2015-12-31 13F MEDNAX COM 58502B106 2,000 123 6.55 143 0.00 0.0990
2015-10-28 2015-09-30 13F MEDNAX COM 58502B106 1,877 -5 -0.27 143 4.38 0.0987
2015-08-12 2015-06-30 13F MEDNAX COM 58502B106 1,882 1,882 137 0.0872
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.